On February 28, Ra Medical Systems Inc. (RMED) announced to have filed a 510(k) application for its DABRA Catheter with the FDA. Consequently, the stock
On February 17, 2022, shares of Ra Medical Systems Inc. (RMED) made a comeback in the after-hours session. There is no new announcement or SEC
Ra Medical Systems, Inc. (RMED) gained in the pre-market after announcing its 10th patent. RMED values at $0.42, gaining more than 4% compared to yesterday’s
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.